R-CHOP is an established standard of care for treatment-naïve ... cell Engager Therapeutic to co-engage activating receptors on NK cells (NKp46 and CD16), IL-2R (but not the alpha subunit) through a ...

After dropping its only clinical-stage candidate last month, ADC Therapeutics is shutting down ... The company said the R&D site closure and layoffs are expected to be complete by Sept.

"These updated results further support the potential of ZYNLONTA as an effective single-agent treatment for patients with r/r MZL, including high-risk POD24 patients," said Lossos, the study's ...

R. Kelly now claims he suffered an overdose requiring immediate medical attention after taking pills given to him by staff while in solitary confinement Scott Olson/Getty R. Kelly claims, in a ...

LAUSANNE, Switzerland, June 16, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE ... to treat relapsed/refractory marginal zone lymphoma (r/r MZL) will be presented during a poster session at ...

Novel combination of acimtamig and an allogenic natural killer cell product shows safety and promising objective response ...

"These updated results further support the potential of ZYNLONTA as an effective single-agent treatment for patients with r/r MZL, including high-risk POD24 patients," said Lossos, the study's ...

Simcere has been evaluating the CDH6-targeted ADC, dubbed SIM0505, in an ongoing early-stage trial in the company’s home territory of China. NextCure’s strategy for the asset involves ...

The 'Game of Thrones' author addresses the pressure to finish 'The Winds of Winter' with a rather blunt reaction to some fan assumptions: "I know you've given up on me...." By James Hibberd Writer ...

Ron Killings, best known under his WWE ring name R-Truth, is parting ways with the company he's called home for nearly two decades. Killings announced the shocking news Sunday on social media ...